#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	4556	16S	1529	1529	99.87	16S.l6.c17.ctg.1	2478	540.2	0	.	n	.	0	C207T	SNP	207	207	C	625	625	T	624	T,C,G	409,149,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	4556	16S	1529	1529	99.87	16S.l6.c17.ctg.1	2478	540.2	0	.	n	.	0	C1450T	SNP	1450	1450	C	1868	1868	T	641	T,C	432,173	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	4556	16S	1529	1529	99.87	16S.l6.c17.ctg.1	2478	540.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1602	1602	C	650	C	595	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	4556	16S	1529	1529	99.87	16S.l6.c17.ctg.1	2478	540.2	0	HET	.	.	.	C451T,A,G	.	451	451	C	869	869	C	612	C,T,A,G	405,140,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	7242	23S	2890	2890	99.9	23S.l6.c4.ctg.1	4050	535.9	0	.	n	.	0	T695C	SNP	695	695	T	1256	1256	C	589	C,A	516,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	7242	23S	2890	2890	99.9	23S.l6.c4.ctg.1	4050	535.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2532	2532	C	596	C	544	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	7242	23S	2890	2890	99.9	23S.l6.c4.ctg.1	4050	535.9	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3158	3158	T	610	T,G	539,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	7242	23S	2890	2890	99.9	23S.l6.c4.ctg.1	4050	535.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2606	2606	A	613	A,T	568,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	734	folP	855	855	100.0	folP.l15.c4.ctg.1	2157	102.0	1	SNP	p	R229S	1	.	.	685	687	AGC	1387	1389	AGC	170;168;168	A;G;C	152;151;151	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1466	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3922	111.8	1	SNP	p	S91F	1	.	.	271	273	TTC	833	835	TTC	125;125;126	T;T;C	110;114;114	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1466	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3922	111.8	1	SNP	p	D95G	1	.	.	283	285	GGC	845	847	GGC	119;118;119	G;G;C	105;108;107	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1466	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3922	111.8	1	SNP	p	G95N	0	.	.	283	285	GGC	845	847	GGC	119;118;119	G;G;C	105;108;107	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	690	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1942	106.6	1	SNP	p	G45D	0	.	.	133	135	GGC	857	859	GGC	175;175;175	G;G;C	165;163;163	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	474	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c4.ctg.1	1498	94.8	0	.	n	.	0	A197.	DEL	197	197	A	829	829	A	182	A	170	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1382	parC	2304	2304	100.0	parC.l6.c17.ctg.1	3364	122.9	1	SNP	p	D86N	0	.	.	256	258	GAC	782	784	GAC	122;122;123	G;A;C	110;107;110	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1382	parC	2304	2304	100.0	parC.l6.c17.ctg.1	3364	122.9	1	SNP	p	R87W	0	.	.	259	261	CGT	785	787	CGT	123;123;123	C;G,C;T	109;108,1;111	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1382	parC	2304	2304	100.0	parC.l6.c17.ctg.1	3364	122.9	1	SNP	p	R87I	0	.	.	259	261	CGT	785	787	CGT	123;123;123	C;G,C;T	109;108,1;111	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1382	parC	2304	2304	100.0	parC.l6.c17.ctg.1	3364	122.9	1	SNP	p	S87R	1	.	.	259	261	CGT	785	787	CGT	123;123;123	C;G,C;T	109;108,1;111	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1382	parC	2304	2304	100.0	parC.l6.c17.ctg.1	3364	122.9	1	SNP	p	S88P	0	.	.	262	264	TCC	788	790	TCC	123;122;122	T,G;C,T;C	107,1;111,1;106	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	1358	parE	1986	1986	100.0	parE.l6.c4.ctg.1	3060	132.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1790	1792	GGC	184;182;183	G,C;G;C	161,1;158;163	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	1174	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2765	126.6	1	SNP	p	A311V	0	.	.	931	933	GCC	1406	1408	GCC	140;138;137	G;C;C	128;120;129	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1174	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2765	126.6	1	SNP	p	I312M	1	.	.	934	936	ATG	1409	1411	ATG	140;141;142	A;T;G,C	132;129;125,1	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1174	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2765	126.6	1	SNP	p	V316T	1	.	.	946	948	ACC	1421	1423	ACC	145;145;145	A,G;C;C	133,1;131;127	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1174	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2765	126.6	1	SNP	p	T316P	0	.	.	946	948	ACC	1421	1423	ACC	145;145;145	A,G;C;C	133,1;131;127	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1174	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2765	126.6	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1922	1924	ACC	177;178;178	A;C;C	157;151;153	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1174	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2765	126.6	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1976	1978	GCG	174;174;173	G;C;G	153;149;151	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1174	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2765	126.6	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1976	1978	GCG	174;174;173	G;C;G	153;149;151	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1174	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2765	126.6	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2099	2101	GGT	165;166;165	G;G;T	149;147;152	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1174	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2765	126.6	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2108	2110	AGC	161;161;161	A,G;G,T;C	144,2;147,1;146	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	1174	penA	1746	1746	100.0	penA.l15.c17.ctg.1	2765	126.6	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2126	2128	CCG	160;160;160	C,A,G;C;G,T	139,1,1;145;136,1	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1580	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3588	132.0	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1867	1869	CCG	166;166;167	C;C;G,C	146;153;151,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	756	porA	1146	1146	99.91	porA.l15.c4.ctg.1	2358	96.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	796	796	C	128	C	116	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	136	porB1a	984	297	91.03	porB1a.l6.c4.ctg.1	1364	28.7	0	.	p	.	0	H217N	NONSYN	649	651	CAT	1090	1092	AAT	18;17;17	A;A;T	18;17;17	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	136	porB1a	984	297	91.03	porB1a.l6.c4.ctg.1	1364	28.7	0	.	p	.	0	D218N	NONSYN	652	654	GAT	1093	1095	AAT	17;17;17	A;A;T	17;17;17	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	136	porB1a	984	297	91.03	porB1a.l6.c4.ctg.1	1364	28.7	0	.	p	.	0	V226A	NONSYN	676	678	GTA	1117	1119	GCA	15;15;15	G;C;A	15;15;15	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	136	porB1a	984	297	91.03	porB1a.l6.c4.ctg.1	1364	28.7	0	.	p	.	0	.	MULTIPLE	700	702	ACT	1140	1142	GTA	14;14;14	G;T;A	14;13;14	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	136	porB1a	984	297	91.03	porB1a.l6.c4.ctg.1	1364	28.7	0	.	p	.	0	N237fs	FSHIFT	709	709	A	1149	1149	A	12	A	12	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	882	porB1b	1038	1038	99.71	porB1b.l6.c30.ctg.1	2124	123.7	0	.	p	.	0	R144Q	NONSYN	430	432	CGG	983	985	CAG	191;191;191	C;A;G	174;172;175	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	882	porB1b	1038	1038	99.71	porB1b.l6.c30.ctg.1	2124	123.7	0	.	p	.	0	G210R	NONSYN	628	630	GGA	1181	1183	AGA	193;193;194	A;G;A	174;172;174	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	882	porB1b	1038	1038	99.71	porB1b.l6.c30.ctg.1	2124	123.7	0	.	p	.	0	S217G	NONSYN	649	651	AGT	1202	1204	GGT	187;188;188	G;G;T	171;170;169	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	882	porB1b	1038	1038	99.71	porB1b.l6.c30.ctg.1	2124	123.7	1	SNP	p	G120K	1	.	.	358	360	AAG	911	913	AAG	191;190;190	A;A;G	167;167;167	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	882	porB1b	1038	1038	99.71	porB1b.l6.c30.ctg.1	2124	123.7	1	SNP	p	A121N	1	.	.	361	363	AAC	914	916	AAC	190;189;188	A;A;C	157;166;169	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	882	porB1b	1038	1038	99.71	porB1b.l6.c30.ctg.1	2124	123.7	1	SNP	p	N121D	0	.	.	361	363	AAC	914	916	AAC	190;189;188	A;A;C	157;166;169	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	2800	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5321	157.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	422	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1362	92.4	1	SNP	p	V57M	1	.	.	169	171	ATG	737	739	ATG	163;163;164	A,T;T,G;G	147,1;149,1;149	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
